Researchers combined engineered viral vectors with the brain’s glymphatic transport system to deliver genes to glial cells.

A new study describes a gene therapy strategy that uses the brain's own glymphatic transport system to distribute engineered viral vectors throughout the brain.

Axsome Therapeutics, Inc. , a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been dosed in the FOCUS ...

Developers are increasingly relying on large language models (LLMs) for everyday computing tasks such as fixing bugs, ...